Bellevue launches its first active ETF – with a dedicated focus on healthcare stocks

Healthcare is one of the world’s fastest-growing and most resilient sectors, driven by demographic change, rising demand for medical services, and steady innovation. Healthcare spending already accounts for more than 10% of global GDP and 17% of US GDP (Source: WHO). Yet pure index strategies in this sector are often dominated by mega caps, leaving much of the broader growth potential untapped. In addition, the high dispersion of returns within the MSCI World Healthcare Index in 2024 – with the best-performing stock up +131% and the weakest down –58% – underlines the importance of selective exposure 1).

Bellevue is now leveraging these opportunities by applying a high conviction approach to identifying companies with particularly attractive fundamentals and valuations. Proprietary deep-dive research beyond conventional sources and clearly identifiable, time-bound share price catalysts contribute to strengthening investment conviction.

The investment universe is based on the MSCI World Healthcare Index, which comprises 130 to 140 companies worldwide. The Bellevue Healthcare ETF aims to consistently outperform the MSCI Healthcare Index with a UCITS-compliant portfolio of 50 to 100 of the most compelling stocks built through bottom-up fundamental research. The resulting conviction determines whether individual stocks are overweighted or underweighted relative to the index 2).

Bellevue has been a pioneer in the healthcare space ever since its establishment in 1993. The Bellevue Healthcare ETF is co-managed by Marcel Fritsch and Dr. Terence McManus, who bring extensive investment experience in the sector. They are supported by Bellevue’s long-standing Healthcare Team. The ETF will be listed on the SIX Swiss Exchange (CHF, USD) and Deutsche Börse Xetra (EUR), with trading set to begin on September 18, 2025 (SIX) and September 19, 2025 (Xetra). The product is registered in Switzerland and Germany; registration in other countries is pending. The fund's projected total expense ratio (TER) is 0.55%.

Bellevue has partnered with Waystone, a leading provider of specialist services to the global asset management industry. Waystone’s white-label ETF platform provides end-to-end support from set-up to distribution and has guided many of the largest ETF providers entering Europe, building a strong track record of scaling differentiated strategies across the region.

Markus Peter, CEO of Bellevue Asset Management, commented: «Healthcare is a complex and highly dynamic market and that calls for extensive expertise in different facets of the industry. This is precisely where we are strong and where investors can benefit. Our active ETF is suitable for investor needs and wants today. It enables us to leverage our proven healthcare expertise using a fund format that combines transparency, tradability and efficiency with the strengths of an active management approach.»

Paul Heffernan, CEO Waystone ETFs, commented: «The European ETF landscape is undergoing rapid transformation, with active strategies emerging as a key growth driver for asset managers. At Waystone, our platform is purpose-built to offer a scalable and adaptable solution, enabling innovative partners like Bellevue to seamlessly bring their differentiated expertise into the ETF space – without the burden of building infrastructure from scratch. This collaboration underscores our commitment to supporting distinctive investment approaches and expanding their reach across the European market.»

Fund Facts Bellevue Healthcare ETF

Contact
Bellevue Asset Management AG, Theaterstrasse 12, 8001 Zurich,
Tanja Chicherio, +41 44 267 67 00, tch@bellevue.ch

1) Quelle: MSCI 2024, Daten zum 31. Dezember 2024; Hinweis: Die Wertentwicklung in der Vergangenheit ist kein verlässlicher Indikator für zukünftige Ergebnisse und kann irreführend sein.

2) Hinweis: Der Referenzindex «MSCI World Healthcare Index» dient ausschliesslich zu Vergleichszwecken. Der Fonds wird aktiv verwaltet. Kein Referenzindex ist direkt mit einem Fonds identisch, daher ist die Wertentwicklung eines Referenzindex kein verlässlicher Indikator für die zukünftige Wertentwicklung des Fonds, mit dem er verglichen wird.

3) Der Fonds fördert ökologische und soziale Merkmale und investiert nur in Unternehmen, die gute Governance-Praktiken befolgen. Alle Merkmale oder Ziele sowie die eingesetzten ESG-Strategien des beworbenen Fonds entnehmen Sie bitte der spezifischen ESG-Fonds-Offenlegung.

4) Die vollständigen Portfoliobestände und der NAV werden täglich auf der Website des Bellevue Healthcare ETF und der SIX Swiss Exchange veröffentlicht.